Alexandria Real Estate Equities, Inc. with ticker code (ARE) have now 13 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The range between the high target price and low target price is between $186.00 and $118.00 suggesting an average analyst share price target price of $142.08. (at the time of writing). Given that the stocks previous close was at $121.46 this is indicating there is a potential upside of 17.0%. The 50 day moving average now sits at $122.60 and the 200 day MA is $114.96. The market capitalization for the company is 20.65B. The stock price for the company is currently $118.01 USD
The potential market cap would be $24,153,336,699 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 218.54, revenue per share of $16.89 and a 1.27% return on assets.
Alexandria Real Estate Equities, Inc. is a real estate investment trust (REIT). The Company owns, operates, develops and is focused on collaborative life science, agtech, and technology campuses in various cluster locations. It develops urban cluster campuses and ecosystems. Its properties are primarily located in various locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. It has approximately 432 properties in North America containing approximately 47.4 million rentable square feet (RSF) of operating properties and development and redevelopment of new Class A properties (under construction), including 64 properties that are held by consolidated real estate joint ventures and four properties that are held by unconsolidated real estate joint ventures. Its properties include 601, 611, and 651 Gateway Boulevard; Alexandria Center for Life Science-Durham; 275 Grove Street; SD Tech by Alexandria, and Other.
